Sibutramine and Apixaban: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sibutramine
No brand names on recordApixaban
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Taking these two together can raise your risk of bleeding. Apixaban (Eliquis) is a blood thinner. Sibutramine works partly on serotonin and norepinephrine, and medicines that affect those chemicals can make it a little harder for your blood to form clots. Put together, that means bleeding could happen more easily, and in rare cases it can be serious.
This concern is based mostly on how the drugs work rather than a lot of hard data, so please don't panic. Keep taking both exactly as prescribed unless your doctor tells you otherwise, and watch for unusual bruising, bleeding that won't stop, pink or red urine, or black stools. Your care team can manage this safely.
Mechanism: additive pharmacodynamic effect on hemostasis. Apixaban is a direct factor Xa inhibitor; sibutramine (an SNRI-type agent) can impair platelet serotonin-mediated aggregation. Neither is a prodrug relevant here; the effect is additive, not PK-based.
- Direction: increased bleeding risk (additive antihemostatic effect).
- Severity/onset: major; onset unspecified.
- Evidence: theoretical.
- Management: assess baseline bleeding risk; counsel on bleeding signs. Apixaban's PD effect persists at least 24 h after last dose. Discontinue apixaban for active pathologic hemorrhage; specific FXa reversal agent available. PCC, aPCC, or rFVIIa may be considered. During PCC use, PT/INR/aPTT and anti-FXa monitoring are not useful. Activated charcoal reduces apixaban absorption.
What happens
An increased risk of bleeding and can cause serious, potentially fatal bleeding
Interaction Deep Dive
Bleeding risk may rise when apixaban, a factor Xa inhibitor, is given together with other agents that influence hemostasis, such as an SNRI. If active pathological bleeding develops, apixaban should be stopped. A product capable of reversing apixaban's anti-factor Xa activity is on the market. Apixaban's pharmacodynamic effect is anticipated to remain for a minimum of 24 hours following the final dose. Patients should be counseled about the signs and symptoms of blood loss and instructed to report these right away or present to an emergency room. In cases of active pathological hemorrhage, apixaban should be discontinued. An agent that reverses the anti-factor Xa activity of apixaban is available, and the drug's pharmacodynamic effect can be expected to last at least 24 hours after the last dose. Prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa are options that may be considered. If PCCs are administered, tracking apixaban's anticoagulant effect with a clotting assay (PT, INR, or aPTT) or anti-factor Xa (FXa) activity provides no benefit and is not advised. The absorption of apixaban is decreased by activated oral charcoal, which in turn lowers apixaban plasma concentration1.
Why it happens (mechanism)
Additive effects on hemostasis
How to manage this interaction
Keep taking both as prescribed unless your prescriber advises a change. Because the main issue is additive bleeding risk, your care team focuses on awareness and monitoring rather than a set dose change.
- Learn the warning signs: unusual bruising, nosebleeds or gum bleeding that won't stop, pink/red urine, black or bloody stools, coughing or vomiting blood, or severe headache.
- Report any of these right away or go to an emergency room.
- Tell every prescriber and your pharmacist that you take both, and check before adding aspirin, NSAIDs, or other blood thinners.
- If bleeding becomes serious, your doctor can stop apixaban and use a reversal agent; remember its effect lasts at least 24 hours.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Sibutramine and Apixaban together?
Combining apixaban (Eliquis) with sibutramine can increase bleeding risk, so watch closely for any unusual bleeding and report it promptly, but keep taking both as prescribed unless your doctor says otherwise. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sibutramine and Apixaban interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Sibutramine and Apixaban interaction managed?
Keep taking both as prescribed unless your prescriber advises a change. Because the main issue is additive bleeding risk, your care team focuses on awareness and monitoring rather than a set dose change. Learn the warning signs: unusual bruising, nosebleeds or gum bleeding that won't stop, pink/red urine, black or bloody stools, coughing or vomiting blood, or severe headache. Report any of these r… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sibutramine or Apixaban need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
Keep reading about Sibutramine
Keep reading about Apixaban
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist